Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2011, Article ID 189585, 11 pages
http://dx.doi.org/10.4061/2011/189585
Review Article

Primary Biliary Cirrhosis: Family Stories

1Institute of Liver Studies, King’s College London School of Medicine at King’s College Hospital, Denmark Hill Campus, London SE5 9RS, UK
24th Department of Internal Medicine, Medical School of Aristotle University, Hippocration General Hospital of Thessaloniki, 49 Konstantinopoleos Street, Thessaloniki 54642, Greece
3Department of Medicine and Research Laboratory of Internal Medicine, University of Thessaly Medical School, Thessaly, Mezourlo, Larissa 41222, Greece

Received 10 December 2010; Revised 9 February 2011; Accepted 7 March 2011

Academic Editor: I. R. Mackay

Copyright © 2011 Daniel Smyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Hohenester, R. P. J. Oude-Elferink, and U. Beuers, “Primary biliary cirrhosis,” Seminars in Immunopathology, vol. 31, no. 3, pp. 283–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Neuberger, “Primary biliary cirrhosis,” Lancet, vol. 350, no. 9081, pp. 875–879, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. O. E. W. James, R. Bhopal, D. Howel, J. Gray, A. D. Burt, and J. V. Metcalf, “Primary biliary cirrhosis once rare, now common in the United Kingdom?” Hepatology, vol. 30, no. 2, pp. 390–394, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sood, P. J. Gow, J. M. Christie, and P. W. Angus, “Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations,” Gastroenterology, vol. 127, no. 2, pp. 470–475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. W. R. Kim, K. D. Lindor, G. R. Locke et al., “Epidemiology and natural history of primary biliary cirrhosis in a U.S. community,” Gastroenterology, vol. 119, no. 6, pp. 1631–1636, 2000. View at Google Scholar · View at Scopus
  7. M. G. Peters, A. M. Di Bisceglie, K. V. Kowdley et al., “Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States,” Hepatology, vol. 46, no. 3, pp. 769–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. G. P. Watson, P. W. Angus, M. Dewar, B. Goss, R. B. Sewell, and R. A. Smallwood, “Low prevalence of primary biliary cirrhosis in Victoria, Australia,” Gut, vol. 36, no. 6, pp. 927–930, 1995. View at Google Scholar
  9. A. C. Anand, E. Elias, and J. M. Neuberger, “End-stage primary biliary cirrhosis in a first generation migrant south Asian population,” European Journal of Gastroenterology and Hepatology, vol. 8, no. 7, pp. 663–666, 1996. View at Google Scholar · View at Scopus
  10. N. Bach and F. Schaffner, “Familial primary biliary cirrhosis,” Journal of Hepatology, vol. 20, no. 6, pp. 698–701, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Floreani, R. Naccarato, and M. Chiaramonte, “Prevalence of familial disease in primary biliary cirrhosis in Italy,” Journal of Hepatology, vol. 26, no. 3, pp. 737–738, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Tsuji, Y. Watanabe, J. Van De Water et al., “Familial primary biliary cirrhosis in Hiroshima,” Journal of Autoimmunity, vol. 13, no. 1, pp. 171–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Corpechot, Y. Chrétien, O. Chazouillères, and R. Poupon, “Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis,” Journal of Hepatology, vol. 53, no. 1, pp. 162–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. E. J. Jones, F. E. Watt, J. V. Metcalf, M. F. Bassendine, and O. F. W. James, “Familial primary hiliary cirrhosis reassessed: a geographically-based population study,” Journal of Hepatology, vol. 30, no. 3, pp. 402–407, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Brind, G. P. Bray, B. C. Portmann, and R. Williams, “Prevalence and pattern of familial disease in primary biliary cirrhosis,” Gut, vol. 36, no. 4, pp. 615–617, 1995. View at Google Scholar · View at Scopus
  16. K. N. Lazaridis, B. D. Juran, G. M. Boe et al., “Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis,” Hepatology, vol. 46, no. 3, pp. 785–792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Fagan, R. Williams, and S. Cox, “Primary biliary cirrhosis in mother and daughter,” British Medical Journal, vol. 2, no. 6096, p. 1195, 1977. View at Google Scholar · View at Scopus
  18. B. H. Jaup and L. S. W. Zettergren, “Familial occurrence of primary biliary cirrhosis associated with hypergammaglobulinemia in descendants: a family study,” Gastroenterology, vol. 78, no. 3, pp. 549–555, 1980. View at Google Scholar · View at Scopus
  19. M. J. Tong, K. M. Nies, T. B. Reynolds, and F. P. Quismorio, “Immunological studies in familial primary biliary cirrhosis,” Gastroenterology, vol. 71, no. 2, pp. 305–307, 1976. View at Google Scholar · View at Scopus
  20. M. von Mach, “Primary biliary cirrhosis in classmates:coincidence of enigmatic environmental influence?” EXCLI, vol. 1, pp. 1–7, 2002. View at Google Scholar
  21. M. E. Gershwin, C. Selmi, H. J. Worman et al., “Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients,” Hepatology, vol. 42, no. 5, pp. 1194–1202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. I. Prince, S. J. Ducker, and O. F. W. James, “Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations,” Gut, vol. 59, no. 4, pp. 508–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Liu, P. Invernizzi, Y. Lu et al., “Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 658–660, 2010. View at Publisher · View at Google Scholar
  24. G. M. Hirschfield, X. Liu, Y. Han et al., “Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 655–657, 2010. View at Publisher · View at Google Scholar
  25. G. M. Hirschfield, X. Liu, C. Xu et al., “Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants,” New England Journal of Medicine, vol. 360, no. 24, pp. 2544–2555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Selmi, M. J. Mayo, N. Bach et al., “Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment,” Gastroenterology, vol. 127, no. 2, pp. 485–492, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Abu-Mouch, C. Selmi, G. D. Benson et al., “Geographic clusters of primary biliary cirrhosis,” Clinical and Developmental Immunology, vol. 10, no. 2–4, pp. 127–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. G. Douglas and N. D. C. Finlayson, “Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis?” British Medical Journal, vol. 2, no. 6187, pp. 419–420, 1979. View at Google Scholar · View at Scopus
  29. D. P. Bogdanos, H. Baum, and D. Vergani, “Antimitochondrial and other autoantibodies,” Clinics in Liver Disease, vol. 7, no. 4, pp. 759–777, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. P. Bogdanos, P. Invernizzi, I. R. Mackay, and D. Vergani, “Autoimmune liver serology: current diagnostic and clinical challenges,” World Journal of Gastroenterology, vol. 14, no. 21, pp. 3374–3387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Courvalin and H. J. Worman, “Nuclear envelope protein autoantibodies in primary biliary cirrhosis,” Seminars in Liver Disease, vol. 17, no. 1, pp. 79–90, 1997. View at Google Scholar · View at Scopus
  32. C. Dähnrich, A. Pares, L. Caballeria et al., “New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies,” Clinical Chemistry, vol. 55, no. 5, pp. 978–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Liu, G. L. Norman, Z. Shums et al., “PBC Screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis,” Journal of Autoimmunity, vol. 35, no. 4, pp. 436–442, 2010. View at Publisher · View at Google Scholar
  34. D. P. Bogdanos and L. Komorowski, “Disease-specific autoantibodies in primary biliary cirrhosis,” Clinica Chimica Acta, vol. 412, no. 7-8, pp. 502–512, 2011. View at Publisher · View at Google Scholar
  35. M. D. Van Norstrand, M. Malinchoc, K. D. Lindor et al., “Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression,” Hepatology, vol. 25, no. 1, pp. 6–11, 1997. View at Google Scholar · View at Scopus
  36. E. I. Rigopoulou, D. P. Bogdanos, C. Liaskos et al., “Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 118–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. I. Rigopoulou, E. T. Davies, D. P. Bogdanos et al., “Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis,” Liver International, vol. 27, no. 9, pp. 1226–1231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. E. I. Rigopoulou, E. T. Davies, A. Pares et al., “Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis,” Gut, vol. 54, no. 4, pp. 528–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Miyachi, R. W. Hankins, H. Matsushima et al., “Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study,” Journal of Autoimmunity, vol. 20, no. 3, pp. 247–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Nakamura, H. Kondo, T. Mori et al., “Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis,” Hepatology, vol. 45, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. D. P. Bogdanos, C. Liaskos, A. Pares et al., “Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis,” Hepatology, vol. 45, no. 6, p. 1583, 2007. View at Publisher · View at Google Scholar
  42. D.-P. Bogdanos, C. Liaskos, E. I. Rigopoulou, and G. N. Dalekos, “Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen,” Clinica Chimica Acta, vol. 373, no. 1-2, pp. 183–184, 2006. View at Publisher · View at Google Scholar
  43. D.-P. Bogdanos, A. Pares, J. Rodés et al., “Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain,” American Journal of Gastroenterology, vol. 99, no. 4, pp. 763–765, 2004. View at Publisher · View at Google Scholar
  44. D.-P. Bogdanos, D. Vergani, P. Muratori, L. Muratori, and F. B. Bianchi, “Specificity of anti-sp100 antibody for primary biliary cirrhosis,” Scandinavian Journal of Gastroenterology, vol. 39, no. 4, pp. 405–406, 2004. View at Publisher · View at Google Scholar
  45. P. Invernizzi, M. Podda, P. M. Battezzati et al., “Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis,” Journal of Hepatology, vol. 34, no. 3, pp. 366–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Oertelt, R. Rieger, C. Selmi et al., “A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis,” Hepatology, vol. 45, no. 3, pp. 659–665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Vergani and D. P. Bogdanos, “Positive markers in AMA-negative PBC,” American Journal of Gastroenterology, vol. 98, no. 2, pp. 241–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. V. Metcalf, H. C. Mitchison, J. M. Palmer, D. E. Jones, M. F. Bassendine, and O. F. W. James, “Natural history of early primary biliary cirrhosis,” Lancet, vol. 348, no. 9039, pp. 1399–1402, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. H. C. Mitchison, M. F. Bassendine, and A. Hendrick, “Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?” Hepatology, vol. 6, no. 6, pp. 1279–1284, 1986. View at Google Scholar · View at Scopus
  50. J. V. Metcalf, R. S. Bhopal, J. Gray, D. Howel, and O. F. W. James, “Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England,” International Journal of Epidemiology, vol. 26, no. 4, pp. 830–836, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. K. E. Kisand, K. V. Kisand, A. L. Karvonen et al., “Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology,” APMIS, vol. 106, no. 9, pp. 884–892, 1998. View at Google Scholar · View at Scopus
  52. K. D. Lindor, M. E. Gershwin, R. Poupon, M. Kaplan, N. V. Bergasa, and E. J. Heathcote, “Primary biliary cirrhosis,” Hepatology, vol. 50, no. 1, pp. 291–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Szostecki, H. H. Guldner, and H. Will, “Autoantibodies against “nuclear dots” in primary biliary cirrhosis,” Seminars in Liver Disease, vol. 17, no. 1, pp. 71–78, 1997. View at Google Scholar · View at Scopus
  54. J. Wesierska-Gadek, E. Penner, P. M. Battezzati et al., “Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis,” Hepatology, vol. 43, no. 5, pp. 1135–1144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. W. H. Yang, J. H. Yu, A. Nakajima, D. Neuberg, K. Lindor, and D. B. Bloch, “Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?” Clinical Gastroenterology and Hepatology, vol. 2, no. 12, pp. 1116–1122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. E. Gershwin and I. R. Mackay, “Primary biliary cirrhosis: paradigm or paradox for autoimmunity,” Gastroenterology, vol. 100, no. 3, pp. 822–833, 1991. View at Google Scholar · View at Scopus
  57. M. E. Gershwin and I. R. Mackay, “The causes of primary biliary cirrhosis: convenient and inconvenient truths,” Hepatology, vol. 47, no. 2, pp. 737–745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. I. R. Mackay, S. Whittingham, S. Fida et al., “The peculiar autoimmunity of primary biliary cirrhosis,” Immunological Reviews, vol. 174, pp. 226–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. D. P. Bogdanos and D. Vergani, “Origin of cross-reactive autoimmunity in primary biliary cirrhosis,” Liver International, vol. 26, no. 6, pp. 633–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. D. P. Bogdanos and D. Vergani, “Bacteria and primary biliary cirrhosis,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 1, pp. 30–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. D. P. Bogdanos, H. Baum, D. Vergani, and A. K. Burroughs, “The role of E. coli infection in the pathogenesis of primary biliary cirrhosis,” Disease Markers, vol. 29, no. 6, pp. 301–311, 2010. View at Publisher · View at Google Scholar
  62. S. Shimoda, M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho, “HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1835–1845, 1995. View at Google Scholar · View at Scopus
  63. S. Shimoda, M. Nakamura, H. Shigematsu et al., “Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T- cell epitope of primary biliary cirrhosis,” Hepatology, vol. 31, no. 6, pp. 1212–1216, 2000. View at Google Scholar · View at Scopus
  64. S. Shimoda, J. Van De Water, A. Ansari et al., “Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis,” Journal of Clinical Investigation, vol. 102, no. 10, pp. 1831–1840, 1998. View at Google Scholar · View at Scopus
  65. D. E. J. Jones, “Enesis of primary biliary cirrhosis,” Gut, vol. 56, no. 11, pp. 1615–1624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Selmi and M. E. Gershwin, “The role of environmental factors in primary biliary cirrhosis,” Trends in Immunology, vol. 30, no. 8, pp. 415–420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Selmi, P. Invernizzi, M. Zuin, M. Podda, M. F. Seldin, and M. E. Gershwin, “Genes and (auto)immunity in primary biliary cirrhosis,” Genes and Immunity, vol. 6, no. 7, pp. 543–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. R. J. Q. McNally, S. Ducker, and O. F. W. James, “Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis,” Hepatology, vol. 50, no. 4, pp. 1169–1174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Alvaro, P. Invernizzi, P. Onori et al., “Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis,” Journal of Hepatology, vol. 41, no. 6, pp. 905–912, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Amano, P. S. C. Leung, R. Rieger et al., “Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid,” Journal of Immunology, vol. 174, no. 9, pp. 5874–5883, 2005. View at Google Scholar · View at Scopus
  71. K. Amano, P. S. C. Leung, Q. Xu et al., “Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible,” Journal of Immunology, vol. 172, no. 10, pp. 6444–6452, 2004. View at Google Scholar · View at Scopus
  72. D. Bogdanos, T. Pusl, C. Rust, D. Vergani, and U. Beuers, “Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis,” Journal of Hepatology, vol. 49, no. 3, pp. 466–473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. D. P. Bogdanos, H. Baum, M. Okamoto et al., “Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its lactobacillus mimic,” Hepatology, vol. 42, no. 2, pp. 458–465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. D. P. Bogdanos, H. Baum, U. C. Sharma et al., “Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis,” Journal of Hepatology, vol. 36, no. 1, pp. 14–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Invernizzi, M. Miozzo, P. M. Battezzati et al., “Frequency of monosomy X in women with primary biliary cirrhosis,” Lancet, vol. 363, no. 9408, pp. 533–535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. D. E. J. Jones and P. T. Donaldson, “Genetic factors in the pathogenesis of primary biliary cirrhosis,” Clinics in Liver Disease, vol. 7, no. 4, pp. 841–864, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Vergani, D. P. Bogdanos, and H. Baum, “Unusual suspects in primary biliary cirrhosis,” Hepatology, vol. 39, no. 1, pp. 38–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Selmi, P. Invernizzi, M. Zuin, M. Podda, and M. E. Gershwin, “Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology,” Seminars in Liver Disease, vol. 25, no. 3, pp. 265–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Smyk, M. G. Mytilinaiou, E. I. Rigopoulou, and D. P. Bogdanos, “PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York,” Disease Markers, vol. 29, no. 6, pp. 337–344, 2010. View at Publisher · View at Google Scholar
  80. R. Bown, M. L. Clark, and D. Doniach, “Primary biliary cirrhosis in brothers,” Postgraduate Medical Journal, vol. 51, no. 592, pp. 110–115, 1975. View at Google Scholar · View at Scopus
  81. A. Tanaka, A. T. Borchers, H. Ishibashi, A. A. Ansari, C. L. Keen, and M. E. Gershwin, “Genetic and familial considerations of primary biliary cirrhosis,” American Journal of Gastroenterology, vol. 96, no. 1, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Kato, K. Suzuki, and M. Kumagai, “Familial primary biliary cirrhosis. Immunological and genetic study,” American Journal of Gastroenterology, vol. 75, no. 3, pp. 188–191, 1981. View at Google Scholar · View at Scopus
  83. P. Invernizzi, M. Miozzo, C. Selmi et al., “X chromosome monosomy: a common mechanism for autoimmune diseases,” Journal of Immunology, vol. 175, no. 1, pp. 575–578, 2005. View at Google Scholar · View at Scopus
  84. C. Selmi, P. Invernizzi, M. Miozzo, M. Podda, and M. E. Gershwin, “Primary biliary cirrhosis: does X mark the spot?” Autoimmunity Reviews, vol. 3, no. 7-8, pp. 493–499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Miozzo, C. Selmi, B. Gentilin et al., “Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis,” Hepatology, vol. 46, no. 2, pp. 456–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. M. R. Chohan, “Primary biliary cirrhosis in twin sisters,” Gut, vol. 14, no. 3, pp. 213–214, 1973. View at Google Scholar · View at Scopus
  87. C. Selmi, D. L. Balkwill, P. Invernizzi et al., “Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium,” Hepatology, vol. 38, no. 5, pp. 1250–1257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. D. P. Bogdanos, H. Baum, P. Butler et al., “Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection,” Digestive and Liver Disease, vol. 35, no. 11, pp. 801–805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. D. P. Bogdanos, H. Baum, A. Grasso et al., “Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis,” Journal of Hepatology, vol. 40, no. 1, pp. 31–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. D. P. Bogdanos, H. Baum, F. Gunsar et al., “Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity,” Scandinavian Journal of Gastroenterology, vol. 39, no. 10, pp. 981–987, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. D. P. Bogdanos, K. Choudhuri, and D. Vergani, “Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences,” Liver, vol. 21, no. 4, pp. 225–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. D. P. Bogdanos, A. Koutsoumpas, H. Baum, and D. Vergani, “Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis,” Digestive and Liver Disease, vol. 38, no. 10, pp. 781–782, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. D. P. Bogdanos, A. Pares, H. Baum et al., “Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis,” Journal of Autoimmunity, vol. 22, no. 4, pp. 353–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. A. K. Burroughs, P. Butler, M. J. E. Sternberg, and H. Baum, “Molecular mimicry in liver disease,” Nature, vol. 358, no. 6385, pp. 377–378, 1992. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Butler, J. Hamilton-Miller, H. Baum, and A. K. Burroughs, “Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?” Biochemistry and Molecular Biology International, vol. 35, no. 3, pp. 473–485, 1995. View at Google Scholar · View at Scopus
  96. D. Vergani, F. Alvarez, F. B. Bianchi et al., “Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group,” Journal of Hepatology, vol. 41, no. 4, pp. 677–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. A. S. Abdulkarim, L. M. Petrovic, W. R. Kim, P. Angulo, R. V. Lloyd, and K. D. Lindor, “Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?” Journal of Hepatology, vol. 40, no. 3, pp. 380–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Koutsoumpas, M. Mytilinaiou, D. Polymeros, G. N. Dalekos, and D. P. Bogdanos, “Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 10, p. 1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. P. S. C. Leung, O. Park, S. Matsumura, A. A. Ansari, R. L. Coppel, and M. E. Gershwin, “Is there a relation between Chlamydia infection and primary biliary cirrhosis?” Clinical and Developmental Immunology, vol. 10, no. 2–4, pp. 227–233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Mason, L. Xu, Z. Shen et al., “Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus,” Gastroenterology, vol. 127, no. 6, pp. 1863–1865, 2004. View at Publisher · View at Google Scholar
  101. L. Xu, Z. Shen, L. Guo et al., “Does a betaretrovirus infection trigger primary biliary cirrhosis?” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8454–8459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. J. Van de Water, H. Ishibashi, R. L. Coppel, and M. E. Gershwin, “Molecular mimicry and primary biliary cirrhosis: premises not promises,” Hepatology, vol. 33, no. 4, pp. 771–775, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Hemminki, X. Li, K. Sundquist, and J. Sundquist, “Shared familial aggregation of susceptibility to autoimmune diseases,” Arthritis and Rheumatism, vol. 60, no. 9, pp. 2845–2847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. P. T. Donaldson, A. Baragiotta, M. A. Heneghan et al., “HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study,” Hepatology, vol. 44, no. 3, pp. 667–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. M. M. Mitchell, A. Lleo, L. Zammataro et al., “Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis,” Epigenetics, vol. 6, no. 1, pp. 95–102, 2011. View at Publisher · View at Google Scholar
  106. S. M. Rappaport, “Implications of the exposome for exposure science,” Journal of Exposure Science and Environmental Epidemiology, vol. 21, no. 1, pp. 5–9, 2011. View at Publisher · View at Google Scholar
  107. C. P. Wild, “Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 8, pp. 1847–1850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. S. M. Rappaport and M. T. Smith, “Environment and disease risks,” Science, vol. 330, no. 6003, pp. 460–461, 2010. View at Publisher · View at Google Scholar
  109. D. Smyk, E. I. Rigopoulou, H. Baum, A. K. Burroughs, D. Vergani, and D. P. Bogdanos, “Autoimmunity and environment: am I at risk?” Clinical Reviews in Allergy and Immunology. In press. View at Publisher · View at Google Scholar